Search research articles
Contact Us
Filters
Showing results (141-150 of 151) with videos related to
Page
of 16
Sort By:
Plos One
|
October 19, 2012
Genetic KCa3.1-deficiency produces locomotor hyperactivity and alterations in cerebral monoamine levels
Kate Lykke Lambertsen, Jan Bert Gramsbergen, Mithula Sivasaravanaparan, et al.
Metabolites
|
October 2, 2019
In Vivo Microdialysis of Endogenous and <sup>13</sup>C-labeled TCA Metabolites in Rat Brain: Reversible and Persistent Effects of Mitochondrial Inhibition and Transient Cerebral Ischemia
Jesper F Havelund, Kevin H Nygaard, Troels H Nielsen, et al.
Journal of Alzheimer'S Disease : JAD
|
March 28, 2022
Efficacy of Chronic Paroxetine Treatment in Mitigating Amyloid Pathology and Microgliosis in APPSWE/PS1ΔE9 Transgenic Mice
Mithula Sivasaravanaparan, Louise Ørum Olesen, Maurizio Severino, et al.
British Journal of Pharmacology
|
June 25, 2011
Pharmacological activation of KCa3.1/KCa2.3 channels produces endothelial hyperpolarization and lowers blood pressure in conscious dogs
Mads Damkjaer, Gorm Nielsen, Silke Bodendiek, et al.
Biomedical Microdevices
|
July 1, 2015
Fluidic system for long-term in vitro culturing and monitoring of organotypic brain slices
Tanya Bakmand, Ane R Troels-Smith, Maria Dimaki, et al.
Hormones and Behavior
|
May 5, 2009
Age-dependent plasticity of sex pheromone response in the moth, Agrotis ipsilon: combined effects of octopamine and juvenile hormone
David Jarriault, Romina B Barrozo, Carlos J de Carvalho Pinto, et al.
Synapse (New York, N.Y.)
|
April 7, 2007
A PET study of effects of chronic 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on serotonin markers in Göttingen minipig brain
Paul Cumming, Mette Møller, Kjeld Benda, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
June 30, 2018
Established amyloid-β pathology is unaffected by chronic treatment with the selective serotonin reuptake inhibitor paroxetine
Maurizio Severino, Mithula Sivasaravanaparan, Louise Ø Olesen, et al.
Plos One
|
January 17, 2018
Intermittent, low dose carbon monoxide exposure enhances survival and dopaminergic differentiation of human neural stem cells
Nanna Dreyer-Andersen, Ana Sofia Almeida, Pia Jensen, et al.
Scientific Reports
|
February 26, 2016
Glutamate-system defects behind psychiatric manifestations in a familial hemiplegic migraine type 2 disease-mutation mouse model
Pernille Bøttger, Simon Glerup, Bodil Gesslein, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 151) with videos related to
Sort By:
Page
of 16
Plos One
|
October 19, 2012
Genetic KCa3.1-deficiency produces locomotor hyperactivity and alterations in cerebral monoamine levels
Kate Lykke Lambertsen, Jan Bert Gramsbergen, Mithula Sivasaravanaparan, et al.
Metabolites
|
October 2, 2019
In Vivo Microdialysis of Endogenous and <sup>13</sup>C-labeled TCA Metabolites in Rat Brain: Reversible and Persistent Effects of Mitochondrial Inhibition and Transient Cerebral Ischemia
Jesper F Havelund, Kevin H Nygaard, Troels H Nielsen, et al.
Journal of Alzheimer'S Disease : JAD
|
March 28, 2022
Efficacy of Chronic Paroxetine Treatment in Mitigating Amyloid Pathology and Microgliosis in APPSWE/PS1ΔE9 Transgenic Mice
Mithula Sivasaravanaparan, Louise Ørum Olesen, Maurizio Severino, et al.
British Journal of Pharmacology
|
June 25, 2011
Pharmacological activation of KCa3.1/KCa2.3 channels produces endothelial hyperpolarization and lowers blood pressure in conscious dogs
Mads Damkjaer, Gorm Nielsen, Silke Bodendiek, et al.
Biomedical Microdevices
|
July 1, 2015
Fluidic system for long-term in vitro culturing and monitoring of organotypic brain slices
Tanya Bakmand, Ane R Troels-Smith, Maria Dimaki, et al.
Hormones and Behavior
|
May 5, 2009
Age-dependent plasticity of sex pheromone response in the moth, Agrotis ipsilon: combined effects of octopamine and juvenile hormone
David Jarriault, Romina B Barrozo, Carlos J de Carvalho Pinto, et al.
Synapse (New York, N.Y.)
|
April 7, 2007
A PET study of effects of chronic 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on serotonin markers in Göttingen minipig brain
Paul Cumming, Mette Møller, Kjeld Benda, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
June 30, 2018
Established amyloid-β pathology is unaffected by chronic treatment with the selective serotonin reuptake inhibitor paroxetine
Maurizio Severino, Mithula Sivasaravanaparan, Louise Ø Olesen, et al.
Plos One
|
January 17, 2018
Intermittent, low dose carbon monoxide exposure enhances survival and dopaminergic differentiation of human neural stem cells
Nanna Dreyer-Andersen, Ana Sofia Almeida, Pia Jensen, et al.
Scientific Reports
|
February 26, 2016
Glutamate-system defects behind psychiatric manifestations in a familial hemiplegic migraine type 2 disease-mutation mouse model
Pernille Bøttger, Simon Glerup, Bodil Gesslein, et al.
Page
of 16